Jerome Laufer
Papers
1
Total Citations
2
H-Index
1
About
Jerome Laufer is a clinician-researcher whose work centers on the intersection of advanced molecular imaging and urologic oncology, with a particular focus on prostate cancer. His major contributions lie in the application of prostate-specific membrane antigen (PSMA)-targeted PET/CT, notably using 18F-DCFPyL, to detect rare and elusive disease manifestations. In his most cited work (2023), Laufer documented a case of port-site metastasis following robot-assisted laparoscopic radical prostatectomy—an exceptionally rare complication—demonstrating how PSMA PET/CT can identify metastatic spread that conventional imaging might miss. This finding has practical implications for post-surgical surveillance and salvage therapy planning. Though his citation count is still building, his work addresses a critical gap in understanding treatment failure patterns. Laufer’s research helps refine the use of next-generation imaging in prostate cancer management, offering clinicians a clearer roadmap for detecting recurrence and guiding targeted interventions. His contributions are particularly valuable for surgeons and oncologists navigating the complexities of post-prostatectomy disease progression.
Research Focus
Key Achievements
Top Papers
- 1